Javascript must be enabled to continue!
Surfactant lavage for neonatal meconium aspiration syndrome—An updated meta-analysis
View through CrossRef
Background:
Surfactant lavage seems to have a good application prospect both in experimental models and patients with meconium aspiration syndrome (MAS). Data regarding the effect of surfactant lavage on pulmonary complications of MAS are conflicting. In view of these uncertainties, an updated meta-analysis including the latest literatures is performed.
Methods:
A search was conducted by two investigators involved in this research in PubMed, Embase, and Cochrane databases for studies in English and other languages, in Wanfang, VIP, and Cnki databases for Chinese studies (all last launched on December 18, 2018). Ultimately, we identified 11 original studies, including the surfactant lavage group (n = 189) and the control group (n = 204). Odds ratio and weighted mean difference were calculated using a random effects or fixed effects model, depending on the data type and heterogeneity of the included studies.
Results:
The comparison of effectiveness on MAS: (1) With respect to oxygen index at 48 hours stage and 72 hours stage, data showed significant difference between surfactant lavage/control groups (we/ighted mean difference [WMD] = −3.37, 95% confidence interval [CI], −5.68 ~ −1.06; p = 0.004 and 95% CI, −5.03 ~ −2.37; p < 0.00001). (2) With respect to days on mechanical ventilation, the analysis showed that there was significant difference between surfactant lavage group and control group (WMD = −1.12, 95% CI, −1.40 ~ −0.84; p < 0.00001). (3) Regarding the need for extracorporeal membrane oxygenation, days of oxygen therapy, and hospital stay, no significant differences were found. The comparison of possible complications of MAS: (1) Regarding pneumothorax, the analysis showed there was significant difference between surfactant lavage and control groups (odds ratio [OR] = 0.46, 95% CI, 0.24 ~ 0.85; p = 0.01). (2) With respect to mortality, persist pulmonary hypertension and pulmonary hemorrhage, the results showed no difference between the two groups.
Conclusion:
With respect to oxygen index and days on mechanical ventilation, surfactant lavage is significantly effective compared with control group, though didn’t eventually shorten days of oxygen therapy and hospital stay. In addition, our meta-analysis showed that surfactant lavage does not increase the risk of complications.
Ovid Technologies (Wolters Kluwer Health)
Title: Surfactant lavage for neonatal meconium aspiration syndrome—An updated meta-analysis
Description:
Background:
Surfactant lavage seems to have a good application prospect both in experimental models and patients with meconium aspiration syndrome (MAS).
Data regarding the effect of surfactant lavage on pulmonary complications of MAS are conflicting.
In view of these uncertainties, an updated meta-analysis including the latest literatures is performed.
Methods:
A search was conducted by two investigators involved in this research in PubMed, Embase, and Cochrane databases for studies in English and other languages, in Wanfang, VIP, and Cnki databases for Chinese studies (all last launched on December 18, 2018).
Ultimately, we identified 11 original studies, including the surfactant lavage group (n = 189) and the control group (n = 204).
Odds ratio and weighted mean difference were calculated using a random effects or fixed effects model, depending on the data type and heterogeneity of the included studies.
Results:
The comparison of effectiveness on MAS: (1) With respect to oxygen index at 48 hours stage and 72 hours stage, data showed significant difference between surfactant lavage/control groups (we/ighted mean difference [WMD] = −3.
37, 95% confidence interval [CI], −5.
68 ~ −1.
06; p = 0.
004 and 95% CI, −5.
03 ~ −2.
37; p < 0.
00001).
(2) With respect to days on mechanical ventilation, the analysis showed that there was significant difference between surfactant lavage group and control group (WMD = −1.
12, 95% CI, −1.
40 ~ −0.
84; p < 0.
00001).
(3) Regarding the need for extracorporeal membrane oxygenation, days of oxygen therapy, and hospital stay, no significant differences were found.
The comparison of possible complications of MAS: (1) Regarding pneumothorax, the analysis showed there was significant difference between surfactant lavage and control groups (odds ratio [OR] = 0.
46, 95% CI, 0.
24 ~ 0.
85; p = 0.
01).
(2) With respect to mortality, persist pulmonary hypertension and pulmonary hemorrhage, the results showed no difference between the two groups.
Conclusion:
With respect to oxygen index and days on mechanical ventilation, surfactant lavage is significantly effective compared with control group, though didn’t eventually shorten days of oxygen therapy and hospital stay.
In addition, our meta-analysis showed that surfactant lavage does not increase the risk of complications.
Related Results
Maternal and Neonatal Outcome in Meconium Stained Amniotic Fluid at Term in Labour - A Retrospective Study
Maternal and Neonatal Outcome in Meconium Stained Amniotic Fluid at Term in Labour - A Retrospective Study
BACKGROUND Meconium stained amniotic fluid (MSAF) occurs in 12 - 15 % of all deliveries and is frequently associated with adverse outcome in pregnancy. The present study was carrie...
Proportion and associated factors of meconium aspiration syndrome in neonates admitted to NICU Tibebe Ghion Specialized Hospital Bahir Dar Amhara Reginal State North West Ethiopia, 2025
Proportion and associated factors of meconium aspiration syndrome in neonates admitted to NICU Tibebe Ghion Specialized Hospital Bahir Dar Amhara Reginal State North West Ethiopia, 2025
Abstract
Back ground: Meconium aspiration syndrome is defined as respiratory distress in newborn infant born through meconium-stained amniotic fluid whose symptoms can’t be explai...
To Study the Complications of Meconium Aspiration Syndrome & their Outcome In Relation to Gestational Age & Birth Weight In Tertiary Health Care Centre
To Study the Complications of Meconium Aspiration Syndrome & their Outcome In Relation to Gestational Age & Birth Weight In Tertiary Health Care Centre
Neonates born through meconium stained amniotic fluid,2-3% of them develop Meconium Aspiration Syndrome. Out of them,5-10% of them develop complications. Meconium Aspiration is typ...
Diagnostics and treatment of meconium ileus in newborns
Diagnostics and treatment of meconium ileus in newborns
Introduction. Meconium ileus is a disease characterized by the formation of thick, viscous meconium in the lumen of the small intestine with the development of low obstructive inte...
Water-soluble contrast agent during swallowing study increases aspiration sensitivity and antedates oral feeding without respiratory and drug complications: a prospective, observational, case-control Trial v1
Water-soluble contrast agent during swallowing study increases aspiration sensitivity and antedates oral feeding without respiratory and drug complications: a prospective, observational, case-control Trial v1
Water-soluble contrast agent during swallowing study increases aspiration sensitivity and antedates oral feeding without respiratory and drug complications: a prospective, observat...
Physical property measurement of surfactant coupled with nanoparticles for enhanced oil recovery
Physical property measurement of surfactant coupled with nanoparticles for enhanced oil recovery
The residual oil remained in the reservoir after the primary recovery and water flooding can either be produced by increasing the mobility of the oil or by altering the reservoir r...
Clinical profile of babies with meconium stained amniotic fluid
Clinical profile of babies with meconium stained amniotic fluid
Background: Meconium staining of amniotic fluid (MSAF) is a relatively common problem occuring in 10-25% of all deliveries. Meconium aspiration syndrome is more common in term babi...
Budesonide added to modified porcine surfactant curosurf may additionally improve the lung functions in meconium aspiration syndrome
Budesonide added to modified porcine surfactant curosurf may additionally improve the lung functions in meconium aspiration syndrome
Severe meconium aspiration sy ndrome (MAS) in newborns is often treated by exogenous surfac tant. Because its efficacy is reduced by meconium-induced inflammation, glucocorticoid b...

